Full Breakdown
Delays in Research Funding Amid Congressional Budget Approvals
3/1/2026, 10:00:44 PM
Core Event: Funding Delays for Scientific Research Agencies
In 2026, despite the U.S. Congress approving significant funding for scientific research, delays in the release of these funds have hindered the operations of key research agencies, including the National Institutes of Health (NIH), the National Science Foundation (NSF), and NASA. The delays stem from the White House Office of Management and Budget (OMB) implementing new restrictions on how agencies can access their appropriated budgets.
Background & Context: Congressional Action and Budgetary Changes
On February 3, 2026, Congress signed a budget bill that allocated substantial funding for research agencies, rejecting proposed cuts from the administration of President Donald Trump. However, the OMB's slow authorization process has resulted in limited access to these funds. Traditionally, agencies receive immediate permission to spend a portion of their annual budget, but the OMB revised its guidelines, restricting these funds to essential expenses only, such as employee salaries.
Impact on Research Agencies
The NIH, which is the largest public funder of biomedical research globally, has been particularly affected. It has only been able to issue new research awards using leftover funds from a previous budget, leading to a significant slowdown in grant approvals. Reports indicate that the NIH has awarded only about 30% of the new research grants compared to previous years. Similarly, the NSF, which supports a quarter of federally funded basic research at U.S. universities, faced restrictions until the OMB authorized its funding about three weeks after the budget bill was signed.
NASA has also encountered unusual restrictions, with the OMB limiting spending on ten specific science programs, including missions to Venus and Earth-science satellites, until further details on fund usage are provided.
Criticism & Opposition: Calls for Action
Prominent congressional figures, including Rosa DeLauro and Patty Murray, have criticized the OMB's delays, asserting that the agency is required by law to release the funds promptly. DeLauro described the OMB's actions as a "drastic departure from historical practice," emphasizing the need for accountability in the disbursement of public funds. The Republican chairs of the relevant committees have not publicly responded to these concerns.
Official Statements & Responses
Samuel Bagenstos, a former top lawyer for the OMB, remarked on the situation, stating, “It’s a way for the White House to assert more control over how agencies spend their money.” The NIH and the White House have referred inquiries to the OMB, which has not provided a response regarding the delays or the timeline for fund release.
Conflicting Reports & Gaps
While the NIH has reported a significant decrease in grant approvals, the NSF has indicated that with full funding now authorized, it expects award activity to resume. However, the exact timeline for the release of funds and the impact on ongoing research projects remains unclear.
What's Next: Future Implications
The ongoing delays in funding could have long-term effects on scientific research in the U.S., potentially stalling critical projects and innovation. As Congress continues to push for the release of funds, the situation remains dynamic, with stakeholders closely monitoring developments.
